Allele Biotechnology

Allele Biotechnology, founded in 1999, focuses on the development and application of cutting-edge technologies for clinical and therapeutic use. Over the years, Allele Biotechnology has been committed to advancements at the forefront of molecular biology research, including RNA interference, fluorescent proteins, induced pluripotent stem cells (iPSCs), genome editing, and camel-derived single-domain antibodies. In 2015, Allele Biotechnology established a cGMP facility in San Diego to promote the clinical development of iPSC-based cell therapies.